🇺🇸 FDA
Patent

US 8911728

High-affinity fully functional soluble single-domain human CD4, antibodies, and related fusion proteins

granted A61PA61P31/18

Quick answer

US patent 8911728 (High-affinity fully functional soluble single-domain human CD4, antibodies, and related fusion proteins) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P31/18